TECHNOLOGY
A Novel Method for Production of Rare Carotenoids from Commercially Available Lutein

Print Save as PDF

Overview

Anhydrolutein, a-cryptoxanthin, b-cryptoxanthin and zeaxanthin are among the 12 major dietary carotenoids which are found in human serum, milk, major organs, and tissues. Industrial production of a wide range of purified carotenoids is of great importance in view of the role of carotenoids in the prevention of chronic diseases like cancer, age-related macular degeneration, and cardiovascular disease. Several dietary carotenoids like b-carotene, lutein, and lycopene are commercially availablle in various formulations. a-cryptoxanthin, b-cryptoxanthin and zeaxanthin are among rare carotenoids in nature and as a result extraction and isolation of these carotenoids from industrial scale is not commercially viable.

A researcher in the Department of Chemistry and Biochemistry has developed a novel method that converts commercially available lutein to a mixture of a-cryptoxanthin and b-cryptoxanthin and minor quantities of anhydrolutein in one synthetic steps.

Contact Info

UM Ventures
0134 Lee Building
7809 Regents Drive
College Park, MD 20742
Email: [email protected]
Phone: (301) 405-3947 | Fax: (301) 314-9502